Letter: Wait until Biden’s negotiations make these medications cheaper

(AP Photo/M. Spencer Green, File)

A very interesting reality is the fact that the ten drugs whose price the Biden administration intends to negotiate about with Medicare are all advertised repetitively on TV these days.

They are: Bristol Myers Squibb’s blood thinner Eliquis, Boehringer Ingelheim and Eli Lilly’s diabetes drug Jardiance, Johnson & Johnson’s blood thinner Xarelto, Merck’s diabetes drug Januvia, AstraZeneca’s diabetes drug Farxiga, Novartis’ heart failure treatment Entresto, Amgen’s rheumatoid arthritis drug Enbrel, Johnson & Johnson and AbbVie’s blood cancer treatment Imbruvica, J&J’s anti-inflammatory medicine Stelara, and Novo Nordisk insulins that go by names including Fiasp and NovoLog.

If you consider asking your doctor about them as the ads suggest, wait until the cost decreases.

Louis Borgenicht, Salt Lake City

Submit a letter to the editor